Aldose Reductase: A Promising Therapeutic Target for High-Altitude Pulmonary Edema
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26010341 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Dan Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Disease of Tibet Autonomous Region, School of Medicine, Xi…. Hauptthemen laut MEDLINE: Aldehyde Reductase, Altitude Sickness, Hypertension, Pulmonary, Pulmonary Edema. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tibet Autonomous Region, Youth project of Xizang Minzu University.
Abstract (Originalsprache)
The Qinghai–Tibet Plateau, famously known as the “Roof of the World”, has witnessed a surge in individuals traveling or working there. However, a considerable percentage of these individuals may suffer from acute mountain sickness (AMS), with high-altitude pulmonary edema (HAPE) being a severe and potentially life-threatening manifestation. HAPE disrupts the balance of intrapulmonary tissue fluid, resulting in severe lung function impairment. Current therapeutic interventions for HAPE have limitations and are accompanied by significant side effects. Aldose reductase (AR), a crucial enzyme in the polyol metabolic pathway, has been implicated in various diseases. In this study, we sought to explore the role of AR in HAPE. Utilizing both in vivo and in vitro models, we investigated the impact of AR on hypoxia-induced pulmonary edema, vascular pressure, inflammatory factors, and oxidative stress. Our findings revealed that AR knockdown mitigated hypoxia-induced pulmonary edema, decreased the expression of vascular pressure and inflammatory factors, and enhanced the expression related to oxidative stress. These results indicate that AR may serve as a potential therapeutic target for HAPE, offering a plausible pathological basis and novel drug targets for the prevention and treatment of this condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Disease of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang 712082, China.
ORCID-Profile: Dan Song
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Tibet Autonomous Region
- Youth project of Xizang Minzu University
- Graduate Research Innovation and Practice Project of Xizang Minzu University
Zitieren
APA
Song, D., Wang, M., Zhao, X., Zhang, Y., Zhang, Y., Hao, X., Yuan, J., & Tang, H. (2025). Aldose Reductase: A Promising Therapeutic Target for High-Altitude Pulmonary Edema. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010341
Vancouver
Song D, Wang M, Zhao X, Zhang Y, Zhang Y, Hao X, et al. Aldose Reductase: A Promising Therapeutic Target for High-Altitude Pulmonary Edema. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26010341
BibTeX
@article{Song2025,
author = {Song, Dan and Wang, Mengjie and Zhao, Xinjie and Zhang, Yanru and Zhang, Yiyi and Hao, Xiaohua and Yuan, Jialu and Tang, Haojie},
title = {Aldose Reductase: A Promising Therapeutic Target for High-Altitude Pulmonary Edema},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26010341}
}
EUVIMED